Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT00943501

Woman and Man

Extract

This trial is conducted in Europe and the United States of America (USA). The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics (the determination of the concentration of the administered medication in blood over time) and pharmacodynamics (the determination of the effect over time and the duration of action) of multiple doses of liraglutide in the pediatric population (children).


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 2


Links